SARC037: Phase II results of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in patients (pts) with relapsed/refractory Ewing sarcoma (ES) Meeting Abstract
| Authors: | Grohar, P. J.; Ballman, K. V.; Heise, R.; Mascarenhas, L.; Glod, J.; Wedekind, M. F. F.; Gedminas, J. M.; DuBois, S. G.; Maki, R. G.; Crompton, B. D.; Figg, W. D.; Bagatell, R.; Laetsch, T. W.; Diamond, M.; Navid, F.; Roberts, R. D.; Widemann, B. C.; Reinke, D. K.; Chugh, R. |
| Abstract Title: | SARC037: Phase II results of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in patients (pts) with relapsed/refractory Ewing sarcoma (ES) |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557402666 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.11508 |
| Notes: | Meeting Abstract: 11508 -- Source: Wos |
